SUSQUEHANNA INTERNATIONAL GROUP, LLP - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 179 filers reported holding AXSOME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$32,066,231
-24.2%
458,810
-22.0%
0.01%
-25.0%
Q2 2023$42,275,957
+5.7%
588,310
-9.2%
0.01%0.0%
Q1 2023$39,979,619
-39.3%
648,178
-24.1%
0.01%
-50.0%
Q4 2022$65,841,716
+23.3%
853,646
-28.7%
0.02%
+14.3%
Q3 2022$53,395,000
+135.8%
1,196,672
+102.4%
0.01%
+133.3%
Q2 2022$22,646,000
-7.7%
591,304
-0.3%
0.01%
+50.0%
Q1 2022$24,548,000
-51.4%
593,100
-55.6%
0.00%
+300.0%
Q4 2021$50,508,000
+117.1%
1,336,888
+89.4%
0.00%
-75.0%
Q3 2021$23,269,000
-9.6%
705,992
+85.0%
0.00%0.0%
Q2 2021$25,750,000
+50.7%
381,717
+26.5%
0.00%
+33.3%
Q1 2021$17,086,000
-70.0%
301,767
-56.9%
0.00%
-40.0%
Q4 2020$57,012,000
+58.5%
699,776
+38.6%
0.01%
-37.5%
Q3 2020$35,979,000
-2.0%
504,966
+13.2%
0.01%
-11.1%
Q2 2020$36,702,000
-10.8%
446,060
-36.2%
0.01%
-30.8%
Q1 2020$41,147,000
-69.8%
699,422
-47.0%
0.01%
-66.7%
Q4 2019$136,369,000
+654.9%
1,319,354
+47.8%
0.04%
+457.1%
Q3 2019$18,065,000
-50.8%
892,544
-37.3%
0.01%
+75.0%
Q2 2019$36,684,000
+770.5%
1,424,578
+381.0%
0.00%
+33.3%
Q1 2019$4,214,000
+2910.0%
296,146
+492.5%
0.00%
Q4 2018$140,000
+12.9%
49,984
+29.5%
0.00%
Q2 2018$124,000
+195.2%
38,600
+122.9%
0.00%
Q1 2018$42,000
-93.8%
17,318
-85.7%
0.00%
Q4 2017$677,000
+260.1%
120,795
+252.8%
0.00%
Q2 2017$188,000
+64.9%
34,238
+157.4%
0.00%
Q1 2016$114,00013,3020.00%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,008,508$82,980,00048.53%
Fairmount Funds Management LLC 216,098$17,781,0007.93%
WMS Partners, LLC 250,000$20,570,0004.26%
RTW INVESTMENTS, LP 1,658,316$136,446,0003.84%
MORGAN JESS S & CO INC 39,328$3,236,0003.51%
RA Capital Management 2,035,132$167,451,0003.26%
Ghost Tree Capital, LLC 100,000$8,228,0002.17%
ACUTA CAPITAL PARTNERS, LLC 90,000$7,405,0002.14%
Avidity Partners Management LP 404,900$33,315,0002.14%
IRIDIAN ASSET MANAGEMENT LLC/CT 1,085,836$89,343,0001.97%
View complete list of AXSOME THERAPEUTICS INC shareholders